1. Amyloid β protein negatively regulates human platelet activation induced by thrombin receptor-activating protein.
- Author
-
Daisuke Mizutani, Haruhiko Tokuda, Takashi Onuma, Kodai Uematsu, Daiki Nakashima, Kyohei Ueda, Tomoaki Doi, Yukiko Enomoto, Rie Matsushima-Nishiwaki, Shinji Ogura, Hiroki Iida, Osamu Kozawa, and Toru Iwama
- Subjects
THROMBIN receptors ,BLOOD platelet activation ,THROMBIN ,AMYLOID ,HEAT shock proteins ,MITOGEN-activated protein kinases - Abstract
Amyloid β protein deposition in cerebral vessels, a characteristic of Alzheimer's disease, is a risk factor for intracerebral hemorrhage. Amyloid β protein directly modulates human platelet function; however, the exact mechanism of action is unclear. Therefore, we investigated the effects of amyloid β protein on human platelet activation using an aggregometer with laser scattering. Amyloid β protein decreased platelet aggregation induced by thrombin receptor-activating protein, but not by collagen and ADP. Amyloid β protein also suppressed platelet aggregation induced by SCP0237 and A3227. Platelet-derived growth factor-AB secretion and phosphorylated-heat shock protein 27 release by thrombin receptor-activating protein were inhibited by amyloid β protein. Additionally, thrombin receptor-activating protein-induced phosphorylation of JNK and p38 MAP kinase was reduced by amyloid β protein. Collectively, our results strongly suggest that amyloid β protein negatively regulates protease-activated receptor-elicited human platelet activation. These findings may indicate a cause of intracerebral hemorrhage due to amyloid β protein. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF